β¨ Education and Health Notices
2768 NEW ZEALAND GAZETTE No. 127
Change of Class of Flaxmere Intermediate
Dated at Wellington this 6th day of August 1992.
Pursuant to section 153 (1) (b) of the Education Act 1989 (as inserted by section 14 of the Education Amendment Act 1989), I hereby declare that Flaxmere Intermediate will be a composite school (F1β7) on the 1st day of January 1992 and cease to be an intermediate school on that day.
LOCKWOOD SMITH Ph.D., Minister of Education.
go7420
Health
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of a new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Amorolfine 5% as the hydrochloride | Nail lacquer | Laboratoires Sauter SA, Vernier, Switzerland | Loceryl |
Dated this 25th day of April 1992.
Note: This replaces the consent gazetted 30 April 1992.
CHRISTOPHER LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
go7426
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Oxerutins 250 mg | Capsules | Zyma Pharmaceuticals, Nyon, Switzerland | Paroven |
| Atenolol 50 mg/12.5 mg chlorthalidone | Tablets | Gerard Laboratories, Dublin, Ireland | Lo-Ten C |
| Atenolol 50 mg/25 mg chlorthalidone | |||
| Methotrexate 50 mg in 2 ml, 1000 mg in 10 ml, 500 mg in 20 ml | Solution for injection | Delta West Pty Limited, Bentley, Western Australia | Methotrexate injection |
| Morphine sulphate 10 mg/ml | Solution for injection (amp) | Delta West Pty Limited, Bentley, Western Australia | Morphine Sulphate injection |
| Cefodizime 250 mg, 500 mg, 1000 mg, 2000 mg | Powder for reconstitution for injection | Hoechst AG, Frankfurt/Main 80, Germany | Timecef |
| Meningococcal vaccine groups A and C 50 mcg/dose (0.5 ml) purified polysaccharide each group | Vaccine for reconstitution for injection (vial) | SmithKline Beecham Biologicals S.A., Rixensart, Belgium | Mencevax AC |
| Meningococcal vaccine groups A, C, W135 and Y 50 mcg/dose (0.5 ml) purified polysaccharide each group | Vaccine for reconstitution for injection (vial) | SmithKline Beecham Biologicals S.A., Rixensart, Belgium | Mencevax ACWY |
Dated this 31st day of July 1992.
CHRISTOPHER LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
go7425
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1992, No 127
NZLII —
NZ Gazette 1992, No 127
β¨ LLM interpretation of page content
π Change of Class of Flaxmere Intermediate
π Education, Culture & Science6 August 1992
Education, School Classification, Composite School, Flaxmere Intermediate
- LOCKWOOD SMITH Ph.D., Minister of Education
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare25 April 1992
Medicines Act, New Medicine, Amorolfine, Loceryl, Nail Lacquer
- CHRISTOPHER LOVELACE, Director-General of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare31 July 1992
Medicines Act, New Medicines, Oxerutins, Atenolol, Methotrexate, Morphine Sulphate, Cefodizime, Meningococcal Vaccine
- CHRISTOPHER LOVELACE, Director-General of Health